G J Zhang Selected Research

G J Zhang Research Topics

Disease

6	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 05/2022 - 06/2017
4	Neoplasms (Cancer) 09/2020 - 05/2000
2	Neutropenia 04/2022 - 06/2018
2	Infections 06/2019 - 06/2018
2	Acute Promyelocytic Leukemia 08/2017 - 03/2016
1	Urinary Tract Infections (Urinary Tract Infection) 11/2022
1	Stroke (Strokes) 11/2022
1	Dyslipidemias (Dyslipidemia) 03/2022
1	Alzheimer Disease (Alzheimer's Disease) 03/2022
1	Bundle-Branch Block (Fascicular Block) 11/2021
1	Atrioventricular Block 11/2021
1	Mitral Valve Insufficiency (Mitral Regurgitation) 06/2021
1	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 02/2021
1	Philadelphia Chromosome 02/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 09/2020
1	Tumor Lysis Syndrome 06/2020
1	Burkitt Lymphoma (Burkitt's Lymphoma) 06/2020
1	Liver Neoplasms (Liver Cancer) 09/2019
1	Hepatocellular Carcinoma (Hepatoma) 09/2019
1	Coinfection 04/2019
1	Bronchiectasis 04/2019
1	Reinfection 06/2018
1	Sepsis (Septicemia) 06/2018
1	Fever (Fevers) 06/2018
1	Triple Negative Breast Neoplasms 01/2018
1	Invasive Fungal Infections 06/2017
1	Pulmonary Valve Stenosis (Pulmonary Stenosis) 06/2017
1	Patent Ductus Arteriosus 06/2017
1	Hemorrhage 05/2016
1	Acute Coronary Syndrome 12/2015
1	Thrombosis (Thrombus) 12/2015
1	Sudden Infant Death (SID) 03/2015
1	Esophageal Neoplasms (Esophageal Cancer) 11/2014
1	Unilateral Breast Neoplasms 01/2013
1	Breast Neoplasms (Breast Cancer) 01/2013
1	Carcinoma (Carcinomatosis) 05/2000
1	Transitional Cell Carcinoma 05/2000

Drug/Important Bio-Agent (IBA)

3	Cytarabine (Cytosar-U)FDA LinkGeneric 05/2022 - 01/2022
3	HomoharringtonineIBA 05/2022 - 03/2016
2	Anti-Bacterial Agents (Antibiotics)IBA 11/2022 - 06/2018
2	Idarubicin (4 Demethoxydaunorubicin)FDA LinkGeneric 05/2022 - 04/2022
2	Interleukin-6 (Interleukin 6)IBA 04/2019 - 05/2000
2	Proteins (Proteins, Gene)FDA Link 03/2015 - 05/2000
1	leukocyte esteraseIBA 11/2022
1	NitritesIBA 11/2022
1	Daunorubicin (Cerubidine)FDA LinkGeneric 05/2022
1	Cyclophosphamide (Cytoxan)FDA LinkGeneric 04/2022
1	LipidsIBA 03/2022
1	ApolipoproteinsIBA 03/2022
1	Apolipoproteins E (ApoE)IBA 03/2022
1	Azacitidine (5 Azacytidine)FDA Link 01/2022
1	Dasatinib (BMS 354825)FDA Link 02/2021
1	PlatinumIBA 09/2020
1	RNA (Ribonucleic Acid)IBA 09/2020
1	B7-H1 AntigenIBA 09/2020
1	Messenger RNA (mRNA)IBA 09/2020
1	Rituximab (Mabthera)FDA Link 06/2020
1	FructoseIBA 09/2019
1	pegylated granulocyte colony-stimulating factorIBA 06/2019
1	C-Reactive ProteinIBA 04/2019
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2019
1	Interleukin-8 (Interleukin 8)IBA 04/2019
1	plerixafor FDA Link 01/2018
1	posaconazole FDA Link 06/2017
1	Tretinoin (Retinoic Acid)FDA LinkGeneric 03/2016
1	Platelet Membrane GlycoproteinsIBA 12/2015
1	Eptifibatide (Integrilin)FDA Link 12/2015
1	Dietary Fiber FDA Link 03/2015
1	NitrogenIBA 03/2015
1	Insulin-Like Growth Factor I (IGF-1)IBA 03/2015
1	Amino Acid Transport Systems (Amino Acid Transporter)IBA 03/2015
1	Urea (Carbamide)FDA LinkGeneric 03/2015
1	SodiumIBA 03/2015
1	Cisplatin (Platino)FDA LinkGeneric 11/2014
1	Carboplatin (JM8)FDA LinkGeneric 11/2014
1	Etoposide (VP 16)FDA LinkGeneric 11/2014
1	CXCR ReceptorsIBA 01/2013
1	Integrin alpha5beta1IBA 05/2000
1	Fibronectins (Fibronectin)IBA 05/2000

Therapy/Procedure

7	Therapeutics 06/2019 - 05/2000
5	Drug Therapy (Chemotherapy) 04/2022 - 11/2014
2	Induction Chemotherapy 06/2020 - 06/2019
1	Orthopedic Procedures 11/2022
1	Salvage Therapy 01/2022
1	Perioperative Period 11/2021
1	Transcatheter Aortic Valve Replacement 11/2021
1	Surgical Instruments (Clip) 06/2021
1	Adjuvant Chemotherapy 09/2020
1	Lasers (Laser) 09/2019
1	Consolidation Chemotherapy 06/2018
1	Radiotherapy 01/2018
1	Remission Induction 06/2017
1	Blalock-Taussig Procedure 06/2017
1	Percutaneous Coronary Intervention 12/2015